SOPHETHERA

Active pharmaceutical ingredients, isotopes and radioisotopes for medical, therapeutic and diagnostic use; active pharmaceutical ingredients, namely lutetium-177, for medical, therapeutic and diagnostic use; active pharmaceutical ingredients, namely non-carrier added lutetium-177; active pharmaceutical ingredients, namely, a radioisotope for the diagnosis and treatment of oncological diseases and disorders; active pharmaceutical ingredients, namely, a radioisotope for the purpose of increasing the effectiveness of pharmaceutical preparations in the treatment of oncological diseases; active pharmaceutical ingredients that include terbium-149, terbium-152, terbium-155, or terbium-161; active pharmaceutical ingredients that include actinium-225.